Keywords: big, pharma, losing, market, share, brazil, generics
Big pharma losing market share in Brazil as generics rise
Article | 23 July 2001
The top five pharmaceutical manufacturers in Brazil together held 25% ofthe national drug market last year, compared with 28% in 1998, according to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
